Bristol Myers reports shortage of chemo drug abraxane; Sartorius more than doubles capacity with Michigan expansion
Manufacturing delays have led to a shortage in abraxane, Bristol Myers Squibb says.
The announcement comes on the heels of the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
